SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001963745-23-000051
Filing Date
2023-08-15
Accepted
2023-08-15 17:16:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3006
  Complete submission text file 0001963745-23-000051.txt   4398
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Subject) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40522 | Film No.: 231175763
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MONTE ROSA THERAPEUTICS, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Tamboli Ajim (Reporting) CIK: 0001855684 (see all company filings)

Type: 144